--- title: "Everest Medicines (1952) stock: news and investor profile" url: "https://aibio.space/companies/everest-medicines/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Everest Medicines Ltd. (HKEX: 1952), China. The directory classifies it as Pharmaceuticals: Major." --- 1952 Everest Medicines Ltd. HKEX · China # Everest Medicines (1952) news Everest Medicines Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1952, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Everest Medicines news We have not published a story on Everest Medicines yet. When there is news, it will appear here. ## Everest Medicines at a glance - **Ticker**: 1952 - **Listing**: HKEX - **Country**: China ### Related companies - [ImmuneOnco Biopharmaceuticals (Shanghai)](https://aibio.space/companies/immuneonco-biopharmaceuticals-shanghai/) HKEX: 1541 - [Humanwell Healthcare (Group) Co.,Ltd.](https://aibio.space/companies/humanwell-healthcare/) SSE: 600079 - [JIANMIN PHARMACEUTICAL GROUP CO LTD.](https://aibio.space/companies/jianmin-pharmaceutical/) SSE: 600976 - [Shandong Buchang Pharmaceuticals Co.](https://aibio.space/companies/shandong-buchang-pharmaceuticals/) SSE: 603858 - [Zhejiang Hisun Pharmaceutical Co.](https://aibio.space/companies/zhejiang-hisun-pharmaceutical/) SSE: 600267 - [Shanghai OPM Biosciences Co.](https://aibio.space/companies/shanghai-opm-biosciences/) SSE: 688293 - [Gansu Longshenrongfa Pharmaceutical Industry Co.](https://aibio.space/companies/gansu-longshenrongfa-pharmaceutical-industry/) SZSE: 300534 - [Newland Pharmaceutical Co.](https://aibio.space/companies/newland-pharmaceutical/) SZSE: 301277 ### Also on HKEX - [Grand Pharmaceutical Group](https://aibio.space/companies/grand-pharmaceutical/) 512 - [Xuanzhu Biopharmaceutical Co.](https://aibio.space/companies/xuanzhu-biopharmaceutical/) 2575 - [Shanghai Henlius Biotech](https://aibio.space/companies/shanghai-henlius-biotech/) 2696 - [Zai Lab](https://aibio.space/companies/zai-lab/) 9688 - [Antengene Corporation](https://aibio.space/companies/antengene/) 6996 - [Duality Biotherapeutics](https://aibio.space/companies/duality-biotherapeutics/) 9606 ## Questions about Everest Medicines What is the ticker symbol of Everest Medicines? Everest Medicines Ltd. trades under the ticker 1952 on HKEX. Where is Everest Medicines listed? Everest Medicines Ltd. is listed on HKEX. Our directory also records these other listings: GETTEX:6HN; LS:A2QD66; LSX:A2QD66. Which country or territory is Everest Medicines listed under? Our directory records Everest Medicines Ltd. under China. What does Everest Medicines do? Our directory classifies Everest Medicines Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Everest Medicines? The ISIN recorded for Everest Medicines Ltd. is KYG3224E1061. Does aibio.space cover Everest Medicines? aibio.space lists Everest Medicines Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Everest Medicines? Companies in our directory listed in the same country and business area as Everest Medicines: ImmuneOnco Biopharmaceuticals (Shanghai), Humanwell Healthcare (Group) Co.,Ltd., JIANMIN PHARMACEUTICAL GROUP CO LTD., Shandong Buchang Pharmaceuticals Co., Zhejiang Hisun Pharmaceutical Co., Shanghai OPM Biosciences Co.. ## Investor discussion: Everest Medicines Members talk about Everest Medicines (1952). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Everest Medicines, newest first. Each line links the filing it comes from. 1. 2026-06-02 Mergers Transaction under the Listing Rules: (1) MAJOR AND CONNECTED TRANSACTION ACQUISITION OF THE ENTIRE EQUITY INTEREST IN THE TARGET COMPANY AND ASSIGNMENT OF SHAREHOLDER LOAN; AND (2) NOTICE OF EXTRAORDINARY GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0602/2026060202670.pdf) 2. 2026-05-29 Mergers Transaction under the Listing Rules: DELAY IN DESPATCH OF CIRCULAR AND BOOK CLOSURE PERIOD FOR EXTRAORDINARY GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0529/2026052903160.pdf) 3. 2026-04-27 Mergers Transaction under the Listing Rules: SUPPLEMENTAL ANNOUNCEMENT DISCLOSEABLE TRANSACTION IN RELATION TO THE ASSET PURCHASE AGREEMENT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0427/2026042703106.pdf) 4. 2026-04-07 Mergers Transaction under the Listing Rules: MAJOR AND CONNECTED TRANSACTION ACQUISITION OF THE ENTIRE EQUITY INTEREST IN THE TARGET COMPANY AND ASSIGNMENT OF SHAREHOLDER LOAN. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0408/2026040800005.pdf) 5. 2026-03-22 Mergers Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION IN RELATION TO THE ASSET PURCHASE AGREEMENT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0323/2026032300111.pdf) 6. 2025-08-01 Financings Share or debt issue: COMPLETION OF PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0801/2025080103473.pdf) 7. 2025-07-24 Financings Share or debt issue: PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0725/2025072500073.pdf) ## Press releases Headlines of Everest Medicines's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-09-28 HKEXnews [TERMS OF REFERENCE OF THE ENVIRONMENTAL, SOCIAL AND GOVERNANCE COMMITTEE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0928/2026092801947.pdf) 2. 2026-09-28 HKEXnews [ESTABLISHMENT OF ENVIRONMENTAL, SOCIAL AND GOVERNANCE COMMITTEE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0928/2026092801933.pdf) 3. 2026-09-09 HKEXnews [CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE STRATEGIC COOPERATION FRAMEWORK AGREEMENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0909/2026090901073.pdf) 4. 2026-09-03 HKEXnews [VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON THE APPROVAL OF NEW DRUG APPLICATION IN CHINA FOR CARDAMYST FOR THE CONVERSION OF ACUTE SYMPTOMATIC EPISODES OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA TO SINUS RHYTHM IN ADULTS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0903/2026090302275.pdf) 5. 2026-08-18 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0819/2026081900013.pdf) 6. 2026-08-14 HKEXnews [CHANGE OF NON-EXECUTIVE DIRECTOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0814/2026081400750.pdf) 7. 2026-07-17 HKEXnews [GRANT OF OPTIONS AND AWARDS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0717/2026071701527.pdf) 8. 2026-07-07 HKEXnews [VOLUNTARY ANNOUNCEMENT CLOSING OF EXCLUSIVE LICENSE AND COLLABORATION AGREEMENT WITH TRAVERE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0707/2026070701012.pdf) 9. 2026-06-26 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON FRIDAY, 26 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0626/2026062600746.pdf) 10. 2026-06-24 HKEXnews [VOLUNTARY ANNOUNCEMENT COMMERCIALIZATION COLLABORATION RELATING TO HAINAN HERUI'S BUDESONIDE ENTERIC CAPSULES](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0624/2026062400191.pdf) 11. 2026-06-17 HKEXnews [VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY SUBSTANTIAL SHAREHOLDER OF THE COMPANY](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0618/2026061800131.pdf) 12. 2026-06-17 HKEXnews [POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON WEDNESDAY, 17 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0617/2026061700808.pdf) 13. 2026-06-15 HKEXnews [VOLUNTARY ANNOUNCEMENT AGREEMENT WITH DIMERIX TO DEVELOP AND COMMERCIALIZE DMX-200 IN GREATER CHINA, SOUTH KOREA AND SOUTHEAST ASIA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0616/2026061600111.pdf) 14. 2026-06-09 HKEXnews [VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY SUBSTANTIAL SHAREHOLDER OF THE COMPANY](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0610/2026061000037.pdf) 15. 2026-06-07 HKEXnews [VOLUNTARY ANNOUNCEMENT AGREEMENT WITH CORXEL TO DEVELOP AND COMMERCIALIZE LNZ100 IN GREATER CHINA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0608/2026060800005.pdf) 16. 2026-06-02 HKEXnews [Notification Letter to Registered Shareholders - Virtual Meeting Arrangements for the Annual General Meeting](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0602/2026060202782.pdf) 17. 2026-06-02 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0602/2026060202770.pdf) 18. 2026-06-02 HKEXnews [Notification Letter to Registered Shareholders - Virtual Meeting Arrangements for the Extraordinary General Meeting](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0602/2026060202718.pdf) 19. 2026-06-02 HKEXnews [Documents on Display](https://www1.hkexnews.hk/listedco/listconews/sehk/dod/en.html) 20. 2026-06-02 HKEXnews [NOTICE OF EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0602/2026060202684.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:1952 on TradingView](https://www.tradingview.com/symbols/HKEX-1952/). ## Listing details Everest Medicines Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1952, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Everest Medicines Ltd. - **Ticker**: 1952 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Pharmaceuticals: Major - **ISIN**: KYG3224E1061 - **Other listed symbols**: GETTEX:6HN; LS:A2QD66; LSX:A2QD66 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-1952/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/everest-medicines/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Everest Medicines (1952) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/everest-medicines/